IGF1 and X-linked hypophosphatemia: In conclusion, female sex, early initiation of treatment, a higher level of IGF-1, better bone mineralization, and milder rachitic lesions may be the beneficial factors for height among pre-pubertal XLH patients, but the height Z score is not correlated with variant types and recent XLH activity reflected by the ALP level.